Deerfield Mgmt HIF, L.P. is Director & 10% Owner at Larimar Therapeutics, Inc. (LRMR). They have made 6 open-market trades across 4 companies since 2018, most recently 2026-02-27.
CIK 0001665736
4 open-market purchases totalling $112.5M since 2018, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FIXX | 1,988,518 | $33.4M |
| LRMR | 10,622,957 | $21.1M |
| PHGE | 8,938,049 | $16.4M |
| MIRM | 106,162 | $8.5M |
| ONCR | 1,334,976 | $161K |
| Total | $79.7M |
Shares reported on the most recent Form 4, priced at the 2026-03-02 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LRMR | BUY | 2026-02-27 | 2026-03-02 | $5.00 | $25.0M | -14.5% | -16.3% | -36.9% |
| LRMR | BUY | 2025-07-31 | 2025-08-04 | $3.20 | $60.0M | +13.6% | +5.1% | +3.5% |
| ONCR | SELL | 2022-12-22 | 2022-12-27 | $0.27 | $12K | +16.6% | +68.5% | +32.6% |
| LRMR | BUY | 2022-09-16 | 2022-09-20 | $3.15 | $17.5M | -7.0% | -3.2% | +46.8% |
| MIRM | SELL | 2021-07-02 | 2021-07-07 | $16.29 | $2.2M | +1.7% | -5.8% | +7.2% |
| FIXX | BUY | 2018-04-02 | 2018-04-04 | $16.00 | $10.0M | +13.7% | +20.3% | +13.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.